Skip to main content
Premium Trial:

Request an Annual Quote

Intrexon Completes $230M Public Offering

NEW YORK (GenomeWeb) – Intrexon today said that it completed a public offering that raised $230 million in gross proceeds. 

The firm sold 5,609,756 shares of its common stock at $41 per share, which included 731,707 shares purchased by the offering's underwriters under an option granted to them by Intrexon. 

JMP Securities was the sole book-running manager while Stifel was the lead manager on the offering. Griffin Securities and Wunderlich Securities were the co-managers. 

Proceeds will be used for general corporate purposes and strategic acquisitions or investments, the Germantown, Maryland-based synthetic biology firm said when it originally announced the offering last week.